Results 151 to 160 of about 4,731 (194)

Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals. [PDF]

Alzheimers Dement
Nordestgaard LT, Hanson A, Sanderson E, Anderson E, Walker V, Tybjærg-Hansen A, Smith GD, Nordestgaard BG.   +7 more
europepmc   +1 more source

Polyphenol-Rich <i>Opuntia ficus-indica</i> Cladodes: An Integrated Metabolomic, In Vivo and In Silico Study Supporting Their Hypolipidemic and Hepatoprotective Effects. [PDF]

Nutrients
Hadini A, Addous A, Baraich A, Bendada M, Karim A, Choukri M, Mokhtari I, Cordazzo R, Pétriacq P, Amrani S, Bernard A, Bekkaye KE, Rastrelli L, D'Elia M, Harnafi H.   +14 more
europepmc   +1 more source

Genetic Association of Lipids and Lipid-Lowering Drug Target Genes With Atopic Dermatitis: A Drug Target Mendelian Randomization Study. [PDF]

Health Sci Rep
Luo M, Lin J, Zhuo Q, Lin L, Han Y.
europepmc   +1 more source

Research progress on the damage of lipid peroxidation to the body and its correlation with metabolic diseases. [PDF]

Front Mol Biosci
Wang J, Li H, She Y, Xu C, Peng K, Ding W.   +5 more
europepmc   +1 more source

Probiotics in atherosclerosis: mechanisms, efficacy and future directions - a review study. [PDF]

Front Immunol
Cai Y.
europepmc   +1 more source

Lipid, lipid-lowering drugs, and bleedings: A Mendelian randomization and retrospective study. [PDF]

Sci Prog
Guo S, Hu S, Chen H, Chen KY.
europepmc   +1 more source